Qureight
Qureight accelerates clinical trial development at key decision points through data curation and AI-powered decision making. They work with pharmaceutical companies, contract research organisations and hospitals to curate data and help the best drugs get approved: so they can be given to patients who need them the most. Qureight are currently focused on lung and heart disease.
Trading name | Qureight |
---|---|
Sector | HeathTech |
Founders | Dr Muhunthan Thillai & Dr Alessandro Ruggiero |
Date invested | 19/03/2024 |
Date founded | 04/01/2018 |
Status | Current Investment |
Image